Skip to main content
Loading market data...
ETF NYSE Arca USD

iShares Neuroscience and Healthcare ETF IBRN

Issuer: iShares SEC registrant: iShares Trust Equity · Global
Watch IBRN (sign in) Add to portfolio (IBRN) Set an alert for IBRN Compare IBRN with other ETFs Position size calculator for IBRN at 31.91 USD

How position sizing works
Last price 31.91 USD Change: Up +1.12 Percent change: Up +3.64%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Expense ratio
0.47%
Prospectus 28 Nov 2025
Net assets
$5.5M
As of 31 Jul 2026
Holdings
78
As of 31 Jul 2026
12-month distribution yield
1.00%
Yearly
Asset class
Equity
From holdings

iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund listed on NYSE Arca in the United States, issued by iShares. Its category is Equity · Global (equity). Its last price was US$31.91 on 20 Oct 2026. Its expense ratio is 0.47% a year, from its prospectus dated 28 Nov 2025. It reported net assets of US$5.49 million as of 31 Jul 2026. Its latest holdings report lists 78 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.32 a unit, a 12-month distribution yield of 1.00%, paid yearly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.47%
Net, after fee waivers or reimbursements
No waiver stated
Management fee
0.47%
Prospectus date
28 Nov 2025
Filed with the SEC
21 Nov 2025

Source: SEC prospectus risk/return data sets (opens in a new tab) Filed

Size and reporting

Net assets
$5,485,479
Total assets
$6,290,470
Holdings as of
31 Jul 2026
Report made public
23 Sep 2026 (54 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Source: SEC Form N-PORT (opens in a new tab) Filed

Top holdings

Largest 25 of 78 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

IBRN top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY US0669225197 14.64% $803K Short-term investment vehicles (cash funds) United States USD
2 Dianthus Therapeutics Inc US2528281080 5.34% $293K Equity (common) United States USD
3 Xenon Pharmaceuticals Inc CA98420N1050 4.87% $267K Equity (common) Canada USD
4 Praxis Precision Medicines Inc US74006W2070 4.87% $267K Equity (common) United States USD
5 ACADIA PHARMACEUTICALS INC. US0042251084 4.69% $257K Equity (common) United States USD
6 ARROWHEAD PHARMACEUTICALS, INC. US04280A1007 4.65% $255K Equity (common) United States USD
7 ALKERMES PUBLIC LIMITED COMPANY ALKERMES PLC IE00B56GVS15 4.60% $252K Equity (common) Ireland USD
8 Scholar Rock Holding Corp US80706P1030 4.29% $235K Equity (common) United States USD
9 BIOGEN INC. US09062X1037 4.18% $229K Equity (common) United States USD
10 NEUROCRINE BIOSCIENCES, INC. US64125C1099 4.09% $224K Equity (common) United States USD
11 argenx SE US04016X1019 3.86% $212K Other Netherlands USD
12 PTC THERAPEUTICS, INC. US69366J2006 3.85% $211K Equity (common) United States USD
13 AXSOME THERAPEUTICS, INC. US05464T1043 3.77% $207K Equity (common) United States USD
14 Denali Therapeutics Inc US24823R1059 3.67% $201K Equity (common) United States USD
15 Dyne Therapeutics, Inc US26818M1080 3.56% $195K Equity (common) United States USD
16 Edgewise Therapeutics Inc US28036F1057 3.23% $177K Equity (common) United States USD
17 SUPERNUS PHARMACEUTICALS, INC. US8684591089 2.61% $143K Equity (common) United States USD
18 AxoGen, Inc. US05463X1063 2.34% $128K Equity (common) United States USD
19 SK Biopharmaceuticals Co Ltd KR7326030004 2.30% $126K Equity (common) South Korea KRW
20 H. LUNDBECK A/S DK0061804770 1.84% $101K Equity (common) Denmark DKK
21 Biohaven Ltd VGG1110E1079 1.82% $100K Equity (common) British Virgin Islands USD
22 SAREPTA THERAPEUTICS, INC. US8036071004 1.61% $88K Equity (common) United States USD
23 BioArctic AB SE0010323311 1.56% $86K Equity (common) Sweden SEK
24 Taysha Gene Therapies Inc US8776191061 1.50% $82K Equity (common) United States USD
25 Neuren Pharmaceuticals Ltd NZNEUE0001S8 1.48% $81K Equity (common) New Zealand AUD

Source: SEC Form N-PORT (opens in a new tab) Made public Holdings as of 31 Jul 2026

All 78 stored holdings

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 95.51%
Short-term investment vehicles (cash funds) 14.75%
Other 4.38%

Country

Country by weight
CountryWeightBar
United States 85.16%
Canada 5.47%
Ireland 5.01%
Netherlands 3.86%
South Korea 2.42%
Sweden 2.36%
Denmark 1.84%
Switzerland 1.84%
British Virgin Islands 1.82%
New Zealand 1.48%
Japan 0.84%
France 0.75%
Other (7) 1.79%

The country each issuer is assigned to in the report.

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 101.95%
South Korean won (KRW) 2.42%
Swedish krona (SEK) 2.36%
Swiss franc (CHF) 1.97%
Danish krone (DKK) 1.84%
Australian dollar (AUD) 1.48%
Hong Kong dollar (HKD) 1.03%
Japanese yen (JPY) 0.84%
Euro (EUR) 0.76%

The currency each holding is denominated in. Currency hedges are not netted off, so a hedged fund still shows its holdings' currencies.

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 49.14%

Partial coverage: sectors are known for 49.1% of net assets (51% of the fund's equity weight), the holdings matched by CUSIP or ticker to US stocks listed on this site. The rest is not assigned a sector.

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.3200
1 payment per unit
12-month yield
1.00%
Distributions only, not total return
Frequency
Yearly
From the gaps between ex-dates
Latest ex-date
16 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.3200) ÷ latest price ($31.91) × 100 = 1.00%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (4 payments)
IBRN distributions per unit by ex-date
Ex-dateAmount per unit
16 Dec 2025$0.3200
17 Dec 2024$0.1010
20 Dec 2023$0.0060
7 Jun 2023$0.0080

Source: Yahoo Finance (opens in a new tab) Checked · 2 days ago Amounts are adjusted for later unit splits

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources
    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Region and currency: automatic

    Prices stay in each listing's own currency. Your currency is used for totals and for "≈" estimates at the daily reference rate. How this works

    Colour theme